IBDEI06Z ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9156,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,9156,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,9156,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,9157,0)
 ;;=V19.6^^62^525^2
 ;;^UTILITY(U,$J,358.3,9157,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9157,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,9157,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,9157,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,9158,0)
 ;;=V18.2^^62^525^3
 ;;^UTILITY(U,$J,358.3,9158,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9158,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,9158,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,9158,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,9159,0)
 ;;=V17.5^^62^525^5
 ;;^UTILITY(U,$J,358.3,9159,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9159,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,9159,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,9159,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,9160,0)
 ;;=V17.7^^62^525^4
 ;;^UTILITY(U,$J,358.3,9160,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9160,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,9160,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,9160,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,9161,0)
 ;;=V19.0^^62^525^6
 ;;^UTILITY(U,$J,358.3,9161,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9161,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,9161,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,9161,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,9162,0)
 ;;=V16.3^^62^525^7
 ;;^UTILITY(U,$J,358.3,9162,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9162,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,9162,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,9162,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,9163,0)
 ;;=V16.41^^62^525^10
 ;;^UTILITY(U,$J,358.3,9163,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9163,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,9163,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,9163,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,9164,0)
 ;;=V16.42^^62^525^11
 ;;^UTILITY(U,$J,358.3,9164,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9164,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,9164,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,9164,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,9165,0)
 ;;=V16.43^^62^525^12
 ;;^UTILITY(U,$J,358.3,9165,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9165,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,9165,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,9165,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,9166,0)
 ;;=V19.5^^62^525^13
 ;;^UTILITY(U,$J,358.3,9166,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9166,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,9166,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,9166,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,9167,0)
 ;;=V19.2^^62^525^14
 ;;^UTILITY(U,$J,358.3,9167,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9167,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,9167,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,9167,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,9168,0)
 ;;=V17.3^^62^525^16
 ;;^UTILITY(U,$J,358.3,9168,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9168,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,9168,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,9168,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,9169,0)
 ;;=V16.6^^62^525^17
 ;;^UTILITY(U,$J,358.3,9169,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9169,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,9169,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,9169,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,9170,0)
 ;;=V18.61^^62^525^19
 ;;^UTILITY(U,$J,358.3,9170,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9170,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,9170,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,9170,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,9171,0)
 ;;=V17.0^^62^525^20
 ;;^UTILITY(U,$J,358.3,9171,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9171,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,9171,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,9171,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,9172,0)
 ;;=V19.4^^62^525^21
 ;;^UTILITY(U,$J,358.3,9172,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9172,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,9172,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,9172,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,9173,0)
 ;;=V17.1^^62^525^22
 ;;^UTILITY(U,$J,358.3,9173,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9173,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,9173,1,5,0)
 ;;=5^Family h/o Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,9173,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,9174,0)
 ;;=V16.8^^62^525^18
 ;;^UTILITY(U,$J,358.3,9174,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9174,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,9174,1,5,0)
 ;;=5^Family h/o Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,9174,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,9175,0)
 ;;=V11.1^^62^525^41
 ;;^UTILITY(U,$J,358.3,9175,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9175,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,9175,1,5,0)
 ;;=5^Personal h/o Affective Disorder
 ;;^UTILITY(U,$J,358.3,9175,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,9176,0)
 ;;=V15.89^^62^525^49
 ;;^UTILITY(U,$J,358.3,9176,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9176,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,9176,1,5,0)
 ;;=5^Personal h/o Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,9176,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,9177,0)
 ;;=V11.3^^62^525^42
 ;;^UTILITY(U,$J,358.3,9177,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9177,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,9177,1,5,0)
 ;;=5^Personal h/o Alcoholism
 ;;^UTILITY(U,$J,358.3,9177,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,9178,0)
 ;;=V15.07^^62^525^43
 ;;^UTILITY(U,$J,358.3,9178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9178,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,9178,1,5,0)
 ;;=5^Personal h/o Allerlgy to Latex
 ;;^UTILITY(U,$J,358.3,9178,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,9179,0)
 ;;=V13.4^^62^525^44
 ;;^UTILITY(U,$J,358.3,9179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9179,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,9179,1,5,0)
 ;;=5^Personal h/o Arthritis
 ;;^UTILITY(U,$J,358.3,9179,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,9180,0)
 ;;=V12.72^^62^525^45
 ;;^UTILITY(U,$J,358.3,9180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9180,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,9180,1,5,0)
 ;;=5^Personal h/o Colon Polyps
 ;;^UTILITY(U,$J,358.3,9180,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,9181,0)
 ;;=V12.59^^62^525^46
 ;;^UTILITY(U,$J,358.3,9181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9181,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,9181,1,5,0)
 ;;=5^Personal h/o Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,9181,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,9182,0)
 ;;=V45.81^^62^525^47
 ;;^UTILITY(U,$J,358.3,9182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9182,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,9182,1,5,0)
 ;;=5^Personal h/o Coronary Bypass
 ;;^UTILITY(U,$J,358.3,9182,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,9183,0)
 ;;=V15.84^^62^525^48
 ;;^UTILITY(U,$J,358.3,9183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9183,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,9183,1,5,0)
 ;;=5^Personal h/o Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,9183,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,9184,0)
 ;;=V15.85^^62^525^53
 ;;^UTILITY(U,$J,358.3,9184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9184,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,9184,1,5,0)
 ;;=5^Personal h/o Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,9184,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,9185,0)
 ;;=V10.72^^62^525^51
 ;;^UTILITY(U,$J,358.3,9185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9185,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,9185,1,5,0)
 ;;=5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,9185,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,9186,0)
 ;;=V15.3^^62^525^52
 ;;^UTILITY(U,$J,358.3,9186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9186,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,9186,1,5,0)
 ;;=5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,9186,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,9187,0)
 ;;=V10.61^^62^525^26
 ;;^UTILITY(U,$J,358.3,9187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9187,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,9187,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,9187,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,9188,0)
 ;;=V12.03^^62^525^27
 ;;^UTILITY(U,$J,358.3,9188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9188,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,9188,1,5,0)
 ;;=5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,9188,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,9189,0)
 ;;=V10.82^^62^525^28
 ;;^UTILITY(U,$J,358.3,9189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9189,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,9189,1,5,0)
 ;;=5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,9189,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,9190,0)
 ;;=V10.62^^62^525^30
 ;;^UTILITY(U,$J,358.3,9190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9190,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,9190,1,5,0)
 ;;=5^Hx of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,9190,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,9191,0)
 ;;=V10.63^^62^525^29
 ;;^UTILITY(U,$J,358.3,9191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9191,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,9191,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,9191,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,9192,0)
 ;;=V11.2^^62^525^24
 ;;^UTILITY(U,$J,358.3,9192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9192,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,9192,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,9192,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,9193,0)
 ;;=V15.81^^62^525^40
 ;;^UTILITY(U,$J,358.3,9193,1,0)
 ;;=^358.31IA^5^2
